We are committed to serving the best interests of our shareholders.

PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary TESARO, INC. SECURES $60 MILLION IN START-UP FUNDING
Former MGI PHARMA Executives Found New Oncology-Focused Biopharma Company Initial Financing Provided by New Enterprise Associates (NEA) and Management Boston, MA – May 26, 2010 – TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that it has secured $60 million
View HTML